Dibenzothiophene

Dibenzothiophene

SCHEMBL17838083

O=P.c1ccc2c(c1)sc1ccccc12

nearest known ligand 0.82

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR3 P46089 1/20 0.82
▸ ALDH1A1 P00352 6/20 0.60
▸ MAPT P10636 6/20 0.60
▸ RAB9A P51151 2/20 0.60
▸ HPGD P15428 1/20 0.60
▸ SMN1; SMN2 Q16637 1/20 0.60
▸ ALOX15 P16050 1/20 0.52
▸ KDM4E B2RXH2 2/20 0.52
▸ TDP1 Q9NUW8 2/20 0.48
▸ L3MBTL1 Q9Y468 2/20 0.48
▸ POLB P06746 2/20 0.48
▸ CYP1A2 P05177 1/20 0.47
▸ MAOA P21397 1/20 0.47
▸ MAOB P27338 1/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ PTPN7 P35236 1/20 0.44
▸ DUSP3 P51452 1/20 0.44
▸ PTPN12 Q05209 1/20 0.44
▸ PTPN22 Q9Y2R2 1/20 0.44
▸ TNKS O95271 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dibenzothiophene SCHEMBL28316922 0.94 GPR3 (0.93) GPR3ALDH1A1MAPTRAB9AHPGD
Dibenzothiophene SCHEMBL30167635 0.91 GPR3 (1.00) GPR3ALDH1A1MAPTRAB9AHPGD
Dibenzothiophene SCHEMBL14659543 0.91 GPR3 (1.00) GPR3ALDH1A1MAPTRAB9AHPGD
Dibenzothiophene SCHEMBL13294 0.91 GPR3 (1.00) GPR3ALDH1A1MAPTRAB9AHPGD
Dibenzothiophene SCHEMBL11351112 0.88 GPR3 (0.82) GPR3ALDH1A1MAPTRAB9AHPGD
Dibenzothiophene SCHEMBL28345479 0.88 GPR3 (0.82) GPR3ALDH1A1MAPTRAB9AHPGD
Dibenzothiophene SCHEMBL10943387 0.88 GPR3 (0.93) GPR3ALDH1A1MAPTRAB9AHPGD
Dibenzothiophene SCHEMBL21121001 0.88 GPR3 (0.93) GPR3ALDH1A1MAPTRAB9AHPGD
Dibenzothiophene SCHEMBL9934048 0.88 GPR3 (0.93) GPR3ALDH1A1MAPTRAB9AHPGD
Dibenzothiophene SCHEMBL3101427 0.88 GPR3 (0.93) GPR3ALDH1A1MAPTRAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11611046-B2 Organic electroluminescent device MERCK PATENT GMBH (DE) 2023-03-21 — — US disclosed
CN-105283976-B Organic electroluminescent device 默克专利有限公司 2020-11-03 — — CN disclosed
CN-106104839-B Organic electroluminescence device 默克专利有限公司 2018-12-18 — — CN disclosed
CN-105102582-B Organic electroluminescent device 默克专利有限公司 2018-10-12 — — CN disclosed
US-10069079-B2 Organic electroluminescent device with thermally activated delayed fluorescence material MERCK PATENT GMBH (DE) 2018-09-04 — — US disclosed
CN-106104838-B Organic electroluminescence device 默克专利有限公司 2018-07-17 — — CN disclosed
CN-105074950-B Organic electroluminescence device with hot activation delayed fluorescence material 默克专利有限公司 2018-05-11 — — CN disclosed
US-20170092875-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2017-03-30 — — US disclosed
US-20170077418-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2017-03-16 — — US disclosed
CN-106104838-A Organic electroluminescence device 默克专利有限公司 2016-11-09 — — CN disclosed
CN-106104839-A Organic electroluminescence device 默克专利有限公司 2016-11-09 — — CN disclosed
US-20160315268-A1 ORGANIC ELECTROLUMINESCENT DEVICE WITH THERMALLY ACTIVATED DELAYED FLUORESCENCE MATERIAL MERCK PATENT GMBH (DE) 2016-10-27 — — US disclosed
US-20160181545-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2016-06-23 — — US disclosed
CN-105283976-A Organic electroluminescent device MERCK PATENT GMBH 2016-01-27 — — CN disclosed
CN-105102582-A Organic electroluminescent device MERCK PATENT GMBH 2015-11-25 — — CN disclosed
CN-105074950-A Organic electroluminescent device with thermally activated delayed fluorescence material MERCK PATENT GMBH 2015-11-18 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170077418-A1 ORGANIC ELECTROLUMINESCENT DEVICE EPCAM, L1CAM, LAGE3 GPR3 3534/4885ALDH1A1 1035/4885MAPT 550/4885
US-11611046-B2 Organic electroluminescent device EPCAM, L1CAM, LAGE3 GPR3 3534/4885ALDH1A1 1035/4885MAPT 550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback